@miss.jsmiles: Does the body match the face?

Miss Smiles

Open In TikTok:

Region: US

Sunday 09 August 2026 01:25:02 GMT

50099

2855

117

79

Music

Download

No Watermark .mp4 (1.57MB) No Watermark(HD) .mp4 (1.39MB) Watermark .mp4 (0MB) Music .mp3

Comments

Chief153 :

Hell yes

2026-08-09 09:55:15

34

Tony D :

Very beautiful

2026-08-10 14:16:13

46

JPH :

Thunder

2026-08-09 14:37:24

47

Eduardo :

314 Washington ave to Bush Stadium. good times

2026-08-12 17:48:33

23

Young Jedi :

😍

2026-08-14 20:16:17

21

Roberto Murad :

Estoy loco por ti, aunque sé que no me aceptarás como amigo. Me impresionas mucho.🥰🥰🥰

2026-08-09 22:56:11

21

Aubrey Coles :

Most definitely

2026-08-11 03:20:05

23

Jorge V L George :

😍😍😍 Hermosa

2026-08-09 01:28:04

25

Robert Geyer :

BEAUTIFUL

2026-08-11 20:53:06

29

princess Sofia :

go baby

2026-08-13 23:28:39

17

Fawzi Maroc :

i love you so

2026-08-09 03:47:09

26

Kishan Bashir :

hi sweetheart how are you

2026-08-10 11:35:32

21

gergelykiss787 :

😍😍😍

2026-08-12 16:16:38

23

Said Boudiwane :

2026-08-16 12:52:46

10

Fawzi Maroc :

i miss you

2026-08-11 02:53:23

19

Fawzi Maroc :

i miss

2026-08-09 03:50:49

14

Robert Geyer :

🌷🌷

2026-08-21 16:08:25

8

حامد رشید :

wao

2026-08-18 17:37:54

6

Hahaha :

Let’s go Cardinals!

2026-08-12 21:18:27

28

lary med :

2026-08-25 12:24:41

6

Süleyman Ablak :

😘🥰

2026-08-19 19:50:55

6

L B :

2026-08-12 22:33:39

10

🦅الصقر العربي🦅🇩🇿02🇩🇿 :

Good evening, can we talk privately?

2026-08-12 15:27:36

17

To see more videos from user @miss.jsmiles, please go to the Tikwm homepage.

Other Videos

#USAAPartner | “I just want to follow in his footsteps” 🥺❤️ I’m honored to partner with @USAA to tell this Gold Star family’s story about their Marine Sgt. Christopher Jacobs. This Memorial Day, take time to remember those who gave all. #PoppyInMemory

#USAAPartner | “I just want to follow in his footsteps” 🥺❤️ I’m honored to partner with @USAA to tell this Gold Star family’s story about their Marine Sgt. Christopher Jacobs. This Memorial Day, take time to remember those who gave all. #PoppyInMemory

MANDISA WAM🔥🥹🔥 #sama28 #stancenation #static_club #stance #static

MANDISA WAM🔥🥹🔥 #sama28 #stancenation #static_club #stance #static

GLP-1 research is getting much bigger than weight loss. One of the most interesting conversations I had at EASD was during a private scientific roundtable with Lilly’s leadership and a small group of physicians. We talked about something I think deserves more attention: the gap between what researchers initially set out to study and what clinicians are observing in real-world patient care. Sometimes patients report improvements in symptoms or conditions that weren’t part of the original clinical trials. Those observations can raise important questions, but they still need to be studied before we can say whether the medication is responsible. Now, research is expanding into areas like pain and physical function, psoriatic arthritis, inflammatory bowel disease, and women’s health, including the PERIODS trial investigating tirzepatide in PMOS (formerly PCOS). And one of the biggest unanswered questions is whether potential benefits in these conditions are driven by weight loss, effects of the medication itself, or some combination of both. That distinction matters, especially as we think about which patients might benefit from these treatments in the future. There’s a lot we still don’t know. But these are exactly the kinds of questions I’m glad researchers are beginning to investigate. Research in these areas is ongoing. Investigational uses should not be interpreted as established benefits or approved indications. #GLP1 #GLP1Research #EASD2026 #ObesityMedicine #MetabolicHealth

GLP-1 research is getting much bigger than weight loss. One of the most interesting conversations I had at EASD was during a private scientific roundtable with Lilly’s leadership and a small group of physicians. We talked about something I think deserves more attention: the gap between what researchers initially set out to study and what clinicians are observing in real-world patient care. Sometimes patients report improvements in symptoms or conditions that weren’t part of the original clinical trials. Those observations can raise important questions, but they still need to be studied before we can say whether the medication is responsible. Now, research is expanding into areas like pain and physical function, psoriatic arthritis, inflammatory bowel disease, and women’s health, including the PERIODS trial investigating tirzepatide in PMOS (formerly PCOS). And one of the biggest unanswered questions is whether potential benefits in these conditions are driven by weight loss, effects of the medication itself, or some combination of both. That distinction matters, especially as we think about which patients might benefit from these treatments in the future. There’s a lot we still don’t know. But these are exactly the kinds of questions I’m glad researchers are beginning to investigate. Research in these areas is ongoing. Investigational uses should not be interpreted as established benefits or approved indications. #GLP1 #GLP1Research #EASD2026 #ObesityMedicine #MetabolicHealth

#Diosrey #salvoasiego #freefire Dios es rey🙏🫂

#Diosrey #salvoasiego #freefire Dios es rey🙏🫂

About

Robot
API

Legal

Privacy Policy